Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



UK-Based Absolute Antibody Partners with the Recombinant Antibody Network

Redcar, UK, December 3, 2019. Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Recombinant Antibody Network (RAN), a consortium of three expert centers at the University of Chicago, University of Toronto, and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies at a proteome-wide scale.

Read the rest of entry »

Data Magik launches our latest version of clinical trial system “Kapture”

Data Magik is proud to announce the launch of our latest version of clinical trial system “Kapture” and brand new website (www.datakapture.co.uk).

Read the rest of entry »

Aptus Clinical selected as clinical CRO by artelo biosciences

Aptus Clinical has been appointed full service clinical CRO partner by Artelo Biosciences Inc. (through their fully owned UK subsidiary, Trinity R&D Ltd). to deliver the upcoming Phase 1B/2A trial of their synthetic cannabinoid, ART27.13. This latest agreement builds on an earlier research and development partnership agreement, where Aptus successfully designed and supported the critical path pre-clinical experiments and completed key clinical strategy and planning activities for Artelo.

Read the rest of entry »

Precision for Medicine Significantly Expands Berlin Lab as Demand For Immune Monitoring Continues to Grow

BERLIN, GERMANY – 27 NOVEMBER 2019 – Precision for Medicine, part of Precision Medicine Group, today announced that they have opened a new 1,600 m2 Berlin-based laboratory, for the first time combining its proprietary Epiontis ID™ epigenetic immune-monitoring technology with advanced flow cytometry capabilities, along with a full-service biorepository and cell processing laboratory.

Read the rest of entry »

AMSBIO: ELRIG Recognize ScreenIn3D's Technical Innovation

ScreenIn3D, a partner of AMSBIO, has been awarded the prestigious ELRIG Prize for Innovation in Drug Discovery at their flagship conference Drug Discovery 2019 which recently took place in Liverpool, UK.

Read the rest of entry »

OBN Monthly Newsletter for November!

Don't miss out on the November OBN update!

Read the rest of entry »

Oxford BioMaterials

This document lists the equipment belonging to Oxford Biomaterials.

Read the rest of entry »

RSSL launches sterility testing service

Reading Scientific Services Ltd (RSSL) has expanded its microbiology capabilities with the launch of a fast, responsive and flexible sterility testing service for pharmaceutical and medical device companies.

Following the opening of its state-of-the-art microbiology laboratory earlier this year, RSSL has launched a sterility testing service in response to sustained client demand and market growth. The move enables the leading contract research organisation (CRO) to further enhance the scope of its biopharmaceutical services and increase testing capacity. 

“Over the last five years, our pharmaceutical analytical services have experienced tremendous growth, so entering the sterility market is a strategically sound step. It builds on our already diverse range of services which, together with our reputation for quality and scientific excellence, is a compelling combination - particularly for clients who are keen to work with one trusted laboratory.  

“Not only that, in addition to a standard 21-day timeframe for this service, we are also offering clients an expedited 16-day and 14-day, which we believe to be one of the one of the quickest available on the market today,” says Reginald Fernandes, microbiology laboratory manager at RSSL.

RSSL’s new service encompasses two sterility test methods; membrane filtration for aqueous, alcohol, solvent and oil-based products, as well as direct inoculation for non-solubles.  Both are used to determine the presence or absence of contaminating micro-organisms in terminally sterilised or aseptic filtered drug products, in accordance with Ph. Eur, JP and USP regulations.  

Its introduction has been facilitated by further investment in a purpose-designed sterility testing suite, featuring a Grade D clean room installed by Connect2Clean rooms with Grade A Bioquell isolators. The new laboratory is expected to be fully operational from February 2020.

“To mark the launch, we are pleased to offer an exclusive cost-saving offer to every client who engages our sterility test services in the first 12 months. We would also like to extend an open invitation to visit our new facilities and discuss how our full-service microbiology offering can help to achieve individual safety goals,” adds Fernandes.

RSSL’s new sterility testing service is part of its comprehensive range of critical assessment services for manufacturers of sterile products. This complete biopharmaceutical testing package also includes microscopy to reduce the risks of particulate contamination, as well as endotoxin to analyse potential pyrogen contamination. 

To find out more about our new sterility testing service or to discuss your sterility testing requirements with one of our specialists please contact us our team on 0118 918 4076 or via enquiries@rssl.com. 

Link to press release on RSSL website: https://www.rssl.com/news-and-events/news/pharmaceutical-and-biopharmaceutical/2019/new-sterility-testing  

 

Taking Newcastle to the world at BioJapan 2019

Invest Newcastle recently attended BioJapan as part of a UK delegation led by MedCity and supported by the Northern Health Science Alliance (NHSA). Held in Pacifico Yokohoma between 9 and 11 October, BioJapan is Asia’s premier partnering event for the global biotechnology industry with more than 1,000 organisations from 34 countries in attendance. 

Read the rest of entry »

AMSBIO: Transfecting Human Embryonic Stem Cells

AMSBIO reports on how it has worked with Singapore General Hospital (Singapore) to help them identify the best reagent to transfect their human embryonic stems cells.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

https://0123movie.net
izmir sınırsız escort Betboo
konak escort alsancak escort side escort antalya grup escort antalya grup escort ankara rus escort
antalya sınırsız escort sakarya sınırsız escort